Acuzar, Edrazil .
HRN: 22-32-91 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
02/20/2023
CEFUROXIME 1.5GM (VIAL)
02/20/2023
02/20/2023
IV
1.5GM
Prior OR
Prophylaxis For OR
Waiting Final Action
Indication: Prophylaxis Type of Infection: BloodstreamReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes